October 31, 2017
On Sept. 20, 2017, Gov. Carney signed HB 120 into law, which applies to policies that provide coverage for the treatment of stage four advanced metastatic cancer. Such policies are prohibited from mandating that the insured first be required to fail to successfully respond to a different drug or prove a history of failure of such drug before providing benefits for a prescribed drug (sometimes called step therapy). The law is effective for policies issued or renewed on or after Sept. 1, 2017.
This new law doesn’t contain any new employer compliance obligations. However, Delaware employers will want to be aware of the changes to the insurance laws in Delaware should employees have questions regarding health insurance coverage.
HB 120 »